FierceBiotech 25 nov. 2025 <a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a> #Alzheimer disease #Novo Nordisk
Nature News 25 nov. 2025 Semantic design of functional de novo genes from a genomic language model #Published online #language model
Endpoints News 25 nov. 2025 Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial
BioWorld 24 nov. 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld 24 nov. 2025 Novo’s semaglutide fails in phase III Alzheimer’s trials #III Alzheimer #phase III